Medical Doctor Program year 2021 Reported 2019–2021 Source: CMS Open Payments, 2026 publication

Alaleh Akhavan

Dermatology New York, NY Medical Doctor

NPI 1205114709 CMS profile 1388437

200 W 57Th St, Suite 510, New York, NY 10019

Open in the dashboard

General payments

$7,123

42 records reported · program years 2019–2021

Research payments

$0

Paid to them · None reported · program years 2019–2021

Ownership & investment interest

$0

None reported

Through program year 2021, Alaleh Akhavan of New York, NY is reported in the CMS Open Payments database as having received $7,123 across 42 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 72nd percentile of Dermatology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2021 General $651 4
2020 General $5,071 9
2019 General $1,402 29

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Alaleh Akhavan
  • Dermatology median
  • Middle half of Dermatology
  • National median

In program year 2025, general payments to Alaleh Akhavan were reported at $0. Among 10,363 Dermatology profiles paid that year, the median was $788 and the middle half received between $207 and $1,974.

Show as a table
Year Alaleh Akhavan Dermatology median Middle half National median
2019 $1,402 $454 $129–$1,240 $163
2020 $5,071 $235 $81–$756 $114
2021 $651 $377 $108–$1,108 $132
2022 $0 $514 $143–$1,391 $149
2023 $0 $607 $159–$1,674 $160
2024 $0 $751 $204–$1,903 $164
2025 $0 $788 $207–$1,974 $169

Breakdown

Who paid General payments · program years 2019–2021
  1. Galderma Laboratories, L.P. $6,606 21 payments
  2. AbbVie, Inc. $159 3 payments
  3. Ortho Dermatologics, a division of Bausch Health US, LLC $88 5 payments
  4. LEO Pharma Inc. $50 3 payments
  5. Janssen Biotech, Inc. $26 1 payment
  6. Melinta Therapeutics, Inc. $25 1 payment
  7. Sun Pharmaceutical Industries Inc. $25 1 payment
  8. Regeneron Healthcare Solutions, Inc. $23 1 payment
  9. Pfizer Inc. $23 1 payment
  10. Celgene Corporation $22 1 payment
  11. Other $77 4 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2021
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $5,294 3 payments
  2. Food and Beverage $1,482 36 payments
  3. Travel and Lodging $347 3 payments
Products named General payments · program years 2019–2021
  1. SOOLANTRA $6,589 20 payments
  2. ORACEA $932 5 payments
  3. HUMIRA $159 3 payments
  4. ALTRENO $71 4 payments
  5. ONEXTON $71 4 payments
  6. ARAZLO $66 4 payments
  7. EPIDUO FORTE $58 6 payments
  8. ENSTILAR $50 3 payments
  9. TREMFYA $26 1 payment
  10. Baxdela $25 1 payment
  11. Other $267 13 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

42 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dermatology in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2021

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record